Is Anshiping the drug Satralizumab? How much does one cost?

The original drug Satralizumab (Satralizumab) has been launched in China, sold under the brand name Anshiping, and is included in medical insurance. Reimbursement is only available to patients who meet the indications, that is, adolescents and adult patients ≥12 years old with aquaporin 4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD). The price of each box of 120mg (1ml) may be more than RMB 10,000, which is still relatively expensive; the price of each box of the original drug Saterizumab sold overseas is more than $10,000 (the price may fluctuate due to the exchange rate). The ingredients of the original drug sold domestically and abroad are basically the same. There are currently no generic versions of satlizumab available on the market.